Sunland Fund is a venture capital firm established in 2014 and headquartered in Shanghai, China. The firm specializes in investing in early and growth-stage companies within the medical and healthcare sectors. Its focus areas include biomedicine, medical devices such as in vitro diagnostics and genetic technology, minimally invasive interventions, implantable devices, surgical instruments, medical robots, and healthcare services. Sunland Fund seeks to support high-growth segments in the healthcare industry, leveraging a team with expertise in financial and strategic investment, as well as experience in the medical industry.
Aopeng Yiliao is a developer of vascular interventional surgery robots.
Zhitong Technology
Series A in 2024
Zhitong Medical is a provider of computational imaging technology that focuses on the development of surgical vision.
Medtech Technology
Series B in 2024
Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
GenomePrecision
Series C in 2024
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.
Better MedTech
Seed Round in 2024
Better Medtech specializes in innovative solutions for urinary and pelvic floor health. The company focuses on the research and development, production, and sales of specialized medical devices aimed at addressing conditions such as benign prostatic hyperplasia, urinary incontinence, and kidney stones, as well as novel tumor therapies. By providing advanced medical technology and equipment, Better Medtech supports healthcare providers with effective instrument solutions tailored to meet the needs of patients and enhance medical care.
JH Cispoly
Series B in 2023
JH Cispoly specializes in the development of diagnostic technology and equipment specifically designed for gynecological tumors. The company focuses on creating innovative solutions for the early diagnosis of various types of gynecological cancers, including ovarian, cervical, and endometrial cancer. By enhancing early detection capabilities, JH Cispoly aims to improve patient outcomes and facilitate timely treatment for individuals at risk of these conditions.
Juhe Biotechnology
Series B in 2023
Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies.
Precedo Biomedical
Series B in 2023
Precedo Biomedical is a high-tech business that specializes in industrial safety & national strategic biosafety through core cell engineering technologies. It employs the innovation-driven development approach, which leverages scientific and technological innovation to propel industrial innovation, to conduct industrialization and scientific research centered on "cell" issues that impede biomedical development.
Jiyuan Medical
Series A in 2023
Jiyuan Medical focuses on disposable gynecological endoscopes and peripheral products. Its products include disposable electronic hysteroscopes (including 4K high-definition mirrors, resectoscopes, fluoroscopes, near-infrared mirrors, and NBI mirrors), disposable gynecological minimally invasive surgical instruments, hysteroscopes Intelligent workstations, disposable fetoscopes, and disposable mammoscopes to create an overall solution for disposable gynecological endoscopes based on disposable electronic hysteroscopes.
BD Gene Therapeutics
Series B in 2023
BD Gene Therapeutics is a biotechnology company focused on developing gene therapy drugs to address genetic diseases, particularly eye conditions. The company employs a gene-editing platform that utilizes mRNA delivery technology and fourth-generation lentiviral vectors, facilitating the safe and efficient delivery of gene-editing tools like CRISPR. BD Gene Therapeutics is dedicated to discovering innovative treatments for conditions such as diabetic macular degeneration, age-related macular degeneration, and herpes simplex keratitis. In addition to its gene therapy initiatives, the company has also developed antiviral eyedrops and explores applications in tumor immunity and regenerative medicine.
Human Zhizao
Series A in 2023
Human Zhizao is a technology platform that provides comprehensive diagnostic solutions. They provide clinical customers with a parallel, full-automatic multiple flow cytometry fluorescence detection platform and supporting reagents. They provide customer service. The flow fluorescence luminescence technology is a new generation of throughput detection and analysis platform integrating flow analysis, laser analysis, digital signal processing, and other technologies. They involve projects that require the joint detection of multiple indicators, such as autoantibodies, allergens, cytokines, etc.
Hexin Pharmaceutical
Series A in 2023
Hexin Pharmaceutical is a developer of nuclide drugs integrating targeted diagnosis and treatment.
Forethought
Seed Round in 2023
Forethought is engaged in the research and development, production, sales, and service of intelligent and medical devices. They provide products for their classmate xiaoshu spinal detector, spine data acquisition, and analysis system. They offer solutions for hospital testing, student medical examinations, rehabilitation, Fitness Sports Dance Agency, and home guardianship.
Huamu Medical
Series C in 2023
Huamu Medical is a medical device company that uses global innovative technologies to treat cervical spine diseases. It mainly develops and produces new self-locking and absorbable cervical spine cage products. The company's team brings together top domestic material experts and medical experts, and is committed to bringing products to domestic and foreign markets, benefiting the majority of patients with genuine Chinese innovative technologies and products.
Farmove Medical
Series C in 2023
Farmove Medical specializes in the development of medical device technology and provides technical consultation focused on mobile monitoring and early warning systems for chronic diseases, including those affecting the cardiac, nervous, hypertensive, and endocrine systems. The company also engages in research and development of innovative solutions for spinal diseases, particularly self-locking and absorbable cervical fusion cage technologies. By creating advanced medical equipment tailored for spinal disease treatment, Farmove Medical aims to enhance the capabilities of medical facilities in addressing various health challenges.
MEIHUAMEDICAL
Series B in 2022
MEIHUAMEDICAL develops, produces and sells microbial medical instruments & diagnostic reagents.
Prime Gene Therapeutics
Series A in 2022
Prime Gene Therapeutics is committed to becoming a pharmaceutical company. They focus on new drug discovery, R&D, and commercialization in inflammatory diseases and external use. They are also developing and industrialization of innovative drugs.
IMADEK
Series A in 2022
IMADEK specializes in the research, production, and sale of in vitro diagnostic (IVD) products aimed at enhancing blood management and testing processes. The company offers a range of products, including automatic sampling and processing systems, nucleic acid extractors, and intelligent platforms for blood storage. Additionally, IMADEK develops solutions such as cold chain monitoring systems, epidemic control management systems, and data analysis tools. Their offerings cater to various applications, including molecular diagnostics, blood screening, enzyme immunoassays, and mass spectrometry, all with the goal of improving the efficiency and safety of blood supply and testing.
NeuroEchos
Series A in 2022
NeuroEchos, established in August 2017, specializes in functional neurosurgery by offering integrated diagnosis and treatment solutions for conditions linked to abnormal nervous system activity. The company utilizes advanced artificial intelligence to assist in diagnosing and interpreting electroencephalogram (EEG) waves, enhancing the accuracy of neurological assessments. Additionally, NeuroEchos supports neuroscience research through the development and provision of deep brain electrodes, contributing to a better understanding of neurological disorders and improving patient outcomes.
EnnovaBio
Series B in 2021
EnnovaBio is a Chinese pharmaceutical company that specializes in the development of targeted therapeutic drugs. The company focuses on creating innovative immunotherapy pharmaceuticals aimed at treating prevalent autoimmune diseases and brain glioma. By concentrating on both cancer and autoimmune conditions, EnnovaBio seeks to provide effective treatment options that enhance patient outcomes and support medical practitioners in their efforts to address complex health challenges. Through its research and development initiatives, EnnovaBio aims to advance the field of immunotherapy and contribute to improved healthcare solutions in China.
Leo Medical Co.
Venture Round in 2021
Leo Medical is a high-tech medical company that creates, produces, and sells cutting-edge medical products. Leo Medical develops medical devices that use cutting-edge biomedical technology to aid in the diagnosis, intervention, and treatment of disorders of the digestive and circulatory systems. They feel that a minimally invasive technique is the most humane way to treat patients while without sacrificing the procedure's quality. Minimal invasion in medical treatments frequently allows patients to heal faster and doctors to simplify medical operations. It is a win-win situation for everyone. Leo Medical was founded in 2011 and is headquartered in Jiangsu, P.R. China.
JH Cispoly
Seed Round in 2021
JH Cispoly specializes in the development of diagnostic technology and equipment specifically designed for gynecological tumors. The company focuses on creating innovative solutions for the early diagnosis of various types of gynecological cancers, including ovarian, cervical, and endometrial cancer. By enhancing early detection capabilities, JH Cispoly aims to improve patient outcomes and facilitate timely treatment for individuals at risk of these conditions.
Qianglian Zhichuang
Series B in 2020
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.
Suzhou Bonsmile Medical Technology
Series B in 2020
Suzhou Bonsmile Medical Technology Co., Ltd. is a manufacturer specializing in stealth orthodontics products, established in 2016 and located in Suzhou, China. The company develops and offers innovative solutions such as SSP root control technology, SSP3D design software, and cone beam computed tomography (CBCT) imaging technology. These products enable effective dental deformity correction and the customized production of invisible appliances. Bonsmile Medical Technology focuses on providing invisible orthodontic appliances without brackets, along with personalized clear aligners. This approach allows patients to access professional orthodontic services while equipping dentists with safe and advanced orthodontic techniques.
PandaMed
Seed Round in 2019
PandaMed, officially known as Changzhou Zhishan Medical Technology Co., Ltd., is a high-tech company established in May 2017, dedicated to the research, development, and industrialization of non-invasive medical devices focused on diabetes and weight loss. Headquartered in the West Taihu Hi-Tech Industrial Park in Changzhou, the company was founded by a team of domestic and international medical experts and experienced practitioners in the medical equipment field. PandaMed specializes in developing solutions for obese patients, offering services that include an intragastric balloon system and comprehensive health management. The company also has a research and development center located in Shanghai, further enhancing its capacity for innovation in chronic disease treatment and non-invasive weight loss solutions.
DeepWise
Series C in 2019
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
UPPER
Venture Round in 2019
UPPER is a biomedicine manufacturing firm. They provide a maya fluoresence analyzer, an ottoman automatic protein analyzer, and other products. Upper Biotech Pharma markets its products.
Ligatech Bioscience
Series A in 2017
Ligatech Bioscience is an intrusive consumables developer specializing in the development and manufacture of medical devices for the field of sports medicine, as well as the development and production of biomedical materials and products. A production line for artificial ligaments and artificial ligament fixation systems has been established. And provide users with relevant technical advice and technical services.
Regenex Corporation
Angel Round in 2016
Regenex Corporation Co. Ltd. is a pharmaceutical company based in Guangzhou, China, focused on the research, development, and manufacture of a diverse range of medical products. The company specializes in reproductive health medicines, including oral contraceptives such as levonorgestrel enteric-coated tablets and emergency contraceptives, along with condoms that contain water-based lubricants. Additionally, Regenex produces anti-neoplastic drugs, including hydrochloric acid doxorubicin liposome injections, and antibiotic agents like Amphotericin B liposome for injection. The company also develops medications for chronic diseases and geriatric care. Founded in 2003, Regenex emphasizes innovative practices in its marketing strategies, including GPS track management for its personnel.
MicroClear Medical
Series A in 2015
MicroClear Medical specializes in the development and manufacturing of medical instruments aimed at enhancing ophthalmology and optometry imaging services. The company offers a range of high-quality optical equipment, including a confocal retinal ophthalmoscope, a handheld fundus camera, a handheld slit lamp, and a vision screener. Utilizing artificial intelligence technology, MicroClear's products are designed to facilitate improved diagnostic accuracy for healthcare professionals. The company serves hospitals and basic medical institutes worldwide, providing accessible and advanced imaging solutions to support eye care.
GENESKY
Series A in 2015
Genesky provides genetic testing and analysis services for scientific research institutions, medical schools, and biopharmaceutical companies. They also provide different throughputs and different applications of gene analysis services, involving genome sequencing, SNP typing, gene copy number detection, family linkage mapping analysis, metagenomic sequencing, and microbial composition analysis.
Pharmplus
Series B in 2015
Pharmplus is dedicated to building a contemporary chain pharmacy that blends products and services from online and offline sources. For stores, it offers pharmaceutical services. Their goal is to become a professional steward of hundreds of millions of people's health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.